Salmeterol + fluticasone deemed safe for childhood asthma

September 2, 2016

(HealthDay)—Children using a combination long-acting beta agonist/steroid inhaler do not have any greater risk of harm than children using a steroid inhaler alone, according to a study published in the Sept. 1 issue of the New England Journal of Medicine.

Stanley Szefler, M.D., director of pediatric asthma research for the University of Colorado School of Medicine in Aurora, and colleagues recruited 6,208 children between 4 and 11 years old. They were randomly assigned inhalers containing a combination of salmeterol and fluticasone, or fluticasone alone.

Of all the patients, 27 in the combination drug group had a serious asthma-related event that required hospitalization, compared with 21 in the steroid-only group. There were no deaths, and no emergencies that required endotracheal intubation.

"The next step is for the FDA to assemble all the available studies, make their own interpretation, and determine how that would affect product labeling," Szefler told HealthDay.

Several authors disclosed to , including GlaxoSmithKline, which manufactures Advair (fluticasone/salmeterol) and funded the study.

Explore further: ATS: Indacaterol-glycopyrronium cuts COPD exacerbations

More information: Full Text (subscription or payment may be required)

Related Stories

ATS: Indacaterol-glycopyrronium cuts COPD exacerbations

May 16, 2016

(HealthDay)—For patients with a history of chronic obstructive pulmonary disease (COPD) exacerbations, indacaterol-glycopyrronium is more effective for prevention of exacerbations than salmeterol-fluticasone, according ...

1990s trial gave early danger signs for asthma drugs

November 25, 2012

The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.

Recommended for you

Omega-3 supplements can prevent childhood asthma

December 29, 2016

Taking certain omega-3 fatty acid supplements during pregnancy can reduce the risk of childhood asthma by almost one third, according to a new study from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) ...

Cause of inflammation in diabetes identified

November 2, 2016

Inflammation is one of the main reasons why people with diabetes experience heart attacks, strokes, kidney problems and other, related complications. Now, in a surprise finding, researchers at Washington University School ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.